In Vitro Diagnostics Business Analysis Service 2022
DUBLIN, May 5, 2022 /PRNewswire/ -- The "In Vitro Diagnostics Business Outlook" newsletter has been added to ResearchAndMarkets.com's offering.
The twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook will offer the following:
- Market Sizing and Forecasting of IVD Market Segments in Every Issue
- Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care-Updates on the Important Test Categories You Need to Know About
- Industry Watch - Developments with COVID-19 and Other Testing
- M&A, Distribution, Partnerships Tracked and Charted
- New Product Introductions and Company Announcements
- Company Profiling and Quarterly Results Summaries
- Regional Market Coverage
For more information about this newsletter visit https://www.researchandmarkets.com/r/k84msl
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/in-vitro-diagnostics-business-analysis-service-2022-301540605.html
SOURCE Research and Markets
Upcoming Life Sciences Events
- April 2024
- London: BioTrinity 2024
- Singapore: Asia Bio Partnering Forum
- London: LSX World Congress
Latest company news
Clario awarded SAS Global Service Provider Partner of the Year